Kiwanuka, Noah
Mpendo, Juliet
Asiimwe, Stephen
Ssempiira, Julius
Nalutaaya, Annet
Nambuusi, Betty
Wambuzi, Mathias
Kabuubi, Brian
Namuniina, Annemarie
Oporia, Frederick
Nanvubya, Annet
Ssetaala, Ali
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (TA.2011.40200.035)
Article History
Received: 10 October 2017
Accepted: 31 October 2018
First Online: 21 November 2018
Ethics approval and consent to participate
: The protocol was reviewed and approved by the Uganda Virus Research Institute Research and Ethics Committee, and the Uganda National Council for Science and Technology. Written informed consent was obtained from all study participants aged at least 18 years. For participants aged less than 18 years (minors), assent was obtained and consent from a parent or guardian.
: The authors declare that they have no competing interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.